2024-12-30 – Press Releases – www.prnewswire.com
MELBOURNE, Australia and BRUSSELS, Dec. 31, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) and the Brussels-based Oncidium foundation today announce that results for the NOBLE Registry of TLX599-CDx (99mTc-iPSMA) have been published in the…
